Tacrolimus toxicity in a liver-kidney transplant patient receiving Nirmatrelvir/Ritonavir for COVID-19

Due to the rapid approval of some of the newer therapies for COVID-19 infection, there are several pharmacologic aspects of these therapies that are not fully known, including drug-drug interactions. Transplant recipients face notable risks in relation to these interactions. This article outlines co...

Full description

Bibliographic Details
Main Authors: Santiago F. Galeano Lovera, Jhonny W. Perusina, Walid Haddad, Karthik Gnanapandithan
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2023-12-01
Series:Romanian Medical Journal
Subjects:
Online Access:https://rmj.com.ro/articles/2023.4/RMJ_2023_4_Art-06.pdf
_version_ 1827313188746559488
author Santiago F. Galeano Lovera
Jhonny W. Perusina
Walid Haddad
Karthik Gnanapandithan
author_facet Santiago F. Galeano Lovera
Jhonny W. Perusina
Walid Haddad
Karthik Gnanapandithan
author_sort Santiago F. Galeano Lovera
collection DOAJ
description Due to the rapid approval of some of the newer therapies for COVID-19 infection, there are several pharmacologic aspects of these therapies that are not fully known, including drug-drug interactions. Transplant recipients face notable risks in relation to these interactions. This article outlines complications arising from the concurrent administration of nirmatrelvir/ritonavir and tacrolimus in a patient with history of combined kidney and liver transplantation. Additionally, it highlights the effective utilization of phenytoin as an inducer to correct the supratherapeutic levels of tacrolimus.
first_indexed 2024-03-07T21:21:49Z
format Article
id doaj.art-4a0f3dec53c54a70bfcb71043aaea49d
institution Directory Open Access Journal
issn 1220-5478
2069-606X
language English
last_indexed 2024-04-24T21:57:43Z
publishDate 2023-12-01
publisher Amaltea Medical Publishing House
record_format Article
series Romanian Medical Journal
spelling doaj.art-4a0f3dec53c54a70bfcb71043aaea49d2024-03-20T13:59:11ZengAmaltea Medical Publishing HouseRomanian Medical Journal1220-54782069-606X2023-12-0170418418710.37897/RMJ.2023.4.6Tacrolimus toxicity in a liver-kidney transplant patient receiving Nirmatrelvir/Ritonavir for COVID-19Santiago F. Galeano Lovera0Jhonny W. Perusina1Walid Haddad2Karthik Gnanapandithan3Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida, United StatesDepartment of Clinical Research, Mayo Clinic, Jacksonville, Florida, United StatesDepartment of Clinical Research, Mayo Clinic, Jacksonville, Florida, United StatesDepartment of Internal Medicine, Mayo Clinic, Jacksonville, Florida, United StatesDue to the rapid approval of some of the newer therapies for COVID-19 infection, there are several pharmacologic aspects of these therapies that are not fully known, including drug-drug interactions. Transplant recipients face notable risks in relation to these interactions. This article outlines complications arising from the concurrent administration of nirmatrelvir/ritonavir and tacrolimus in a patient with history of combined kidney and liver transplantation. Additionally, it highlights the effective utilization of phenytoin as an inducer to correct the supratherapeutic levels of tacrolimus.https://rmj.com.ro/articles/2023.4/RMJ_2023_4_Art-06.pdfdrug interactiontacrolimuscovid-19renal transplantphenytoin
spellingShingle Santiago F. Galeano Lovera
Jhonny W. Perusina
Walid Haddad
Karthik Gnanapandithan
Tacrolimus toxicity in a liver-kidney transplant patient receiving Nirmatrelvir/Ritonavir for COVID-19
Romanian Medical Journal
drug interaction
tacrolimus
covid-19
renal transplant
phenytoin
title Tacrolimus toxicity in a liver-kidney transplant patient receiving Nirmatrelvir/Ritonavir for COVID-19
title_full Tacrolimus toxicity in a liver-kidney transplant patient receiving Nirmatrelvir/Ritonavir for COVID-19
title_fullStr Tacrolimus toxicity in a liver-kidney transplant patient receiving Nirmatrelvir/Ritonavir for COVID-19
title_full_unstemmed Tacrolimus toxicity in a liver-kidney transplant patient receiving Nirmatrelvir/Ritonavir for COVID-19
title_short Tacrolimus toxicity in a liver-kidney transplant patient receiving Nirmatrelvir/Ritonavir for COVID-19
title_sort tacrolimus toxicity in a liver kidney transplant patient receiving nirmatrelvir ritonavir for covid 19
topic drug interaction
tacrolimus
covid-19
renal transplant
phenytoin
url https://rmj.com.ro/articles/2023.4/RMJ_2023_4_Art-06.pdf
work_keys_str_mv AT santiagofgaleanolovera tacrolimustoxicityinaliverkidneytransplantpatientreceivingnirmatrelvirritonavirforcovid19
AT jhonnywperusina tacrolimustoxicityinaliverkidneytransplantpatientreceivingnirmatrelvirritonavirforcovid19
AT walidhaddad tacrolimustoxicityinaliverkidneytransplantpatientreceivingnirmatrelvirritonavirforcovid19
AT karthikgnanapandithan tacrolimustoxicityinaliverkidneytransplantpatientreceivingnirmatrelvirritonavirforcovid19